STOCK TITAN

Molina Healthcare (MOH) Financials

MOH NYSE
FY2025 annual
Revenue $45.4B +11.7% YoY
Net Income $472.0M -60.0% YoY
EPS (Diluted) $8.92 -56.3% YoY
Free Cash Flow -$636.0M -216.9% YoY
Market Cap $12.2B as of Nov 16, 2026
Price / Sales 0.3x on $44.1B revenue, trailing 12 months to September 30, 2026
Price / Earnings n/m net loss, so no earnings multiple, trailing 12 months to September 30, 2026
Price / Book 2.9x on $4.2B equity, Q3 FY2026

A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Nov 16, 2026; every other figure is from the SEC filings on this page. Not financial advice.

Source SEC Filings (10-K/10-Q) Latest period Q3 FY2026, ended Sep 30, 2026 Reported Currency USD FYE December

Newest figures come from the 10-Q for Q3 FY2026, filed Oct 22, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the MOH SEC filings page.

Molina Healthcare, Inc. (MOH) reported $45.4B in revenue for fiscal year 2025, up 11.7% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI MOH FY2025

FY2025 shows a business with growing revenue but sharply weaker earnings and cash generation as costs outpaced expansion.

The key break is earnings quality: FY2025 net income of $472M coexisted with operating cash flow of -$535M, so reported profit did not translate into cash. That reverses FY2024, when operating cash flow was $644M and free cash flow was $544M, indicating the deterioration was not merely an accounting-margin issue.

Revenue reached $45.4B in FY2025 while cost of revenue reached $39.5B, leaving less of each revenue dollar available after operating costs. Operating margin fell to 1.7% from 4.2% in FY2024, showing that expansion was accompanied by weaker operating conversion.

Long-term debt rose from $2.9B in FY2024 to $3.8B in FY2025, increasing reliance on borrowing. Equity fell to $4.1B while the debt-to-equity ratio reached 0.9x, making the negative cash year more consequential for financial flexibility.

[ NOT FINANCIAL ADVICE ]

Financial Health Signals

Profitability Growth Leverage Liquidity CashFlow Returns 62 / 100
Financial Health Score 62/100

Scored against operating companies for FY2025. Each of the six dimensions is a percentile rank within that peer group, and the overall is the average of the dimensions that can be computed. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of Molina Healthcare, Inc.'s business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Profitability
49

Profitability ranks operating companies on their operating margin with gains on asset sales taken out, averaged over the last three fiscal years with the newest counting most, and in smaller part on how steady that margin has been. Molina Healthcare, Inc. scores 49/100 on it among other operating companies.

Growth
76

Growth ranks operating companies on the yearly rate at which revenue compounded across the last three fiscal years (the last two where the earliest reports no revenue), counted in the currency each company reports in so that a move in the exchange rate is not read as growth. Molina Healthcare, Inc. scores 76/100 on it among other operating companies.

Leverage
86

Molina Healthcare, Inc. held more cash than long-term debt at the end of fiscal year 2025, with $4.2B of cash against $3.8B of long-term debt. Operating companies are ranked here on long-term debt less cash against their EBITDA, where a lower multiple is the safer one, and Molina Healthcare, Inc. scores 86/100 among other operating companies measured the same way.

Liquidity
50

Molina Healthcare, Inc. held $1.69 of current assets for every $1 of current liabilities at the end of fiscal year 2025, a current ratio of 1.69. Liquidity ranks operating companies on that ratio, and Molina Healthcare, Inc. scores 50/100 among other operating companies.

Cash Flow
29

Cash Flow ranks operating companies on their free cash flow margin, which is operating cash flow less capital spending as a share of revenue, averaged over the last three fiscal years with the newest weighted most. Molina Healthcare, Inc. scores 29/100 on it among other operating companies.

Returns
80

Returns ranks operating companies on their return on capital employed, which is operating income against total assets less current liabilities, averaged over three fiscal years with the newest weighted most, and in smaller part on how steady that return has been. Molina Healthcare, Inc. scores 80/100 on it among other operating companies.

Altman Z-Score Safe
4.43

Molina Healthcare, Inc. scores 4.43, well above the 2.99 safe threshold. The largest contribution to the score comes from revenue of $45.4B against total assets of $15.6B. This indicates low bankruptcy risk based on profitability, leverage, and asset efficiency.

Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.

Piotroski F-Score Partial
4/8

Molina Healthcare, Inc. passes 4 of 8 computable financial strength tests (1 of the nine could not be computed from available data). 1 of 4 profitability signals pass, 2 of 3 leverage/liquidity signals pass, the one computable operating efficiency signal (asset turnover improving) passes.

Earnings Quality No Cash Backing

For every $1 of reported earnings, Molina Healthcare, Inc. used $1.13 of operating cash (-$535.0M OCF vs $472.0M net income). Earnings that no cash stands behind rest on accounting accruals, which cannot be repeated indefinitely.

Interest Coverage Adequate
4.07x

Molina Healthcare, Inc. earns $4.07 in operating income for every $1 of interest expense ($781.0M vs $192.0M). This adequate coverage means the company can meet its interest obligations, but has limited cushion if earnings fall.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue
$11.1B
YoY-3.4%
QoQ+1.9%
5Y CAGR+9.5%
10Y CAGR+9.3%

Molina Healthcare, Inc. generated $11.1B in revenue in Q3 2026. This represents a decrease of 3.4% from the same quarter a year earlier. Against the prior quarter it is up 1.9%.

EBITDA
$144.0M
YoY-20.9%
QoQ-22.2%
5Y CAGR-10.7%

Molina Healthcare, Inc.'s EBITDA was $144.0M in Q3 2026, measuring earnings before interest, taxes, depreciation, and amortization. This represents a decrease of 20.9% from the same quarter a year earlier. Against the prior quarter it is down 22.2%.

Net Income
$38.0M
YoY-51.9%
QoQ-36.7%
5Y CAGR-23.3%
10Y CAGR-1.0%

Molina Healthcare, Inc. reported $38.0M in net income in Q3 2026. This represents a decrease of 51.9% from the same quarter a year earlier. Against the prior quarter it is down 36.7%.

EPS (Diluted)
$0.73
YoY-51.7%
QoQ-38.7%
5Y CAGR-21.6%
10Y CAGR-0.4%

Molina Healthcare, Inc. earned $0.73 per diluted share (EPS) in Q3 2026. This represents a decrease of 51.7% from the same quarter a year earlier. Against the prior quarter it is down 38.7%.

Cash & Balance Sheet

Free Cash Flow
-$196.0M
YoYn/m
QoQn/m

Molina Healthcare, Inc. recorded an outflow of $196.0M in free cash flow in Q3 2026, representing a cash shortfall after capex. The change from the same quarter a year earlier is not meaningful, because that figure was zero or negative. The change from the prior quarter is not meaningful, because that quarter’s figure was zero or negative.

Cash & Debt
$4.5B
YoY+6.1%
QoQ-10.2%
5Y CAGR+0.6%
10Y CAGR+4.7%

Molina Healthcare, Inc. held $4.5B in cash against $3.8B in long-term debt as of Q3 2026.

Shares Outstanding
52M
YoY+1.6%
QoQ0.0%
5Y CAGR-2.2%
10Y CAGR-0.8%

Molina Healthcare, Inc. had 52M shares outstanding in Q3 2026. This represents an increase of 1.6% from the same quarter a year earlier. It is unchanged from the prior quarter.

Dividends Per Share

Not reported for Q3 2026.

Margins & Returns

Operating Margin
1.0%
YoY-0.2pp
QoQ-0.4pp
5Y change-2.2pp

Molina Healthcare, Inc.'s operating margin was 1.0% in Q3 2026, reflecting core business profitability. This is down 0.2 percentage points from the same quarter a year earlier. Against the prior quarter it is down 0.4 percentage points.

Net Margin
0.3%
YoY-0.4pp
QoQ-0.2pp
5Y change-1.7pp
10Y change-0.6pp

Molina Healthcare, Inc.'s net profit margin was 0.3% in Q3 2026, showing the share of revenue converted to profit. This is down 0.4 percentage points from the same quarter a year earlier. Against the prior quarter it is down 0.2 percentage points.

Return on Equity
0.9%
YoY-1.0pp
QoQ-0.5pp
5Y change-4.8pp
10Y change-1.6pp

Molina Healthcare, Inc.'s quarterly ROE was 0.9% in Q3 2026: one quarter's net income over shareholder equity, not annualized. This is down 1.0 percentage points from the same quarter a year earlier. Against the prior quarter it is down 0.5 percentage points.

Gross Margin

Not reported for Q3 2026.

Capital Allocation

Share Buybacks
$0
YoY-100.0%
QoQn/m

Molina Healthcare, Inc. repurchased no shares in Q3 2026. This represents a decrease of 100.0% from the same quarter a year earlier. The change from the prior quarter is not meaningful, because that quarter’s figure was zero or negative.

Capital Expenditures
$37.0M
YoY-2.6%
QoQ+23.3%

Molina Healthcare, Inc. invested $37.0M in capex in Q3 2026, funding long-term assets and infrastructure. This represents a decrease of 2.6% from the same quarter a year earlier. Against the prior quarter it is up 23.3%.

R&D Spending

Not reported for Q3 2026.

MOH Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

MOH quarterly income statement
MetricQ3'2610-QQ2'2610-QQ1'2610-QQ4'2510-KQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-K
Revenue$11.1B-3.4%$10.9B-4.8%$10.8B-3.1%$11.4B+8.3%$11.5B+11.0%$11.4B+15.7%$11.1B+12.2%$10.5B+16.0%
Cost of Revenue$9.7B-3.2%$9.4B-4.0%$9.3B-2.2%$10.1B+12.6%$10.0B+16.2%$9.8B+17.5%$9.5B+12.7%$9.0B+20.8%
SG&A Expenses$710.0M-2.6%$724.0M+1.8%$779.0M+0.6%$795.0M+19.5%$729.0M+7.8%$711.0M+2.9%$774.0M+8.9%$665.0M+3.1%
Operating Income$106.0M-22.6%$145.0M-61.1%$83.0M-80.8%-$162.0M-142.6%$137.0M-70.7%$373.0M-14.1%$433.0M+1.6%$380.0M+20.3%
EBITDA$144.0M-20.9%$185.0M-57.1%$122.0M-74.6%-$118.0M-127.6%$182.0M-64.6%$431.0M-10.2%$481.0M+2.1%$428.0M+19.2%
Interest Expense$53.0M+8.2%$54.0M+12.5%$54.0M+25.6%$52.0M+52.9%$49.0M+69.0%$48.0M+71.4%$43.0M+59.3%$34.0M+25.9%
Income Tax$15.0M+66.7%$31.0M-55.7%$15.0M-83.7%-$54.0M-156.8%$9.0M-92.0%$70.0M-33.3%$92.0M-6.1%$95.0M+30.1%
Net Income$38.0M-51.9%$60.0M-76.5%$14.0M-95.3%-$160.0M-163.7%$79.0M-75.8%$255.0M-15.3%$298.0M-1.0%$251.0M+16.2%
EPS (Basic)$0.74-51.0%$1.19-74.9%$0.27-95.1%-$2.88-164.4%$1.51-73.4%$4.75-8.3%$5.47+5.0%$4.47+19.8%
EPS (Diluted)$0.73-51.7%$1.19-74.9%$0.27-95.0%-$2.87-164.5%$1.51-73.3%$4.75-8.1%$5.45+5.4%$4.45+20.6%
Diluted Shares (Avg)52M-1.9%51M-4.5%51M-6.9%N/A53M-9.0%54M-7.7%55M-6.0%N/A

Not reported in any period shown, so not listed: Gross Profit, R&D Expenses.

MOH Balance Sheet

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

MOH quarterly balance sheet
MetricQ3'2610-QQ2'2610-QQ1'2610-QQ4'2510-KQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-K
Total Assets$15.7B-0.3%$16.0B-1.3%$16.4B0.0%$15.6B-0.4%$15.7B-0.4%$16.2B+6.7%$16.4B+5.6%$15.6B+5.0%
Current Assets$12.5B-0.3%$12.9B-1.4%$13.3B+0.5%$12.4B-2.6%$12.6B-2.6%$13.1B+6.3%$13.3B+4.6%$12.8B+1.8%
Cash & Equivalents$4.5B+6.1%$5.0B+10.8%$5.3B+9.4%$4.2B-8.9%$4.2B-10.8%$4.5B+3.3%$4.9B+7.6%$4.7B-3.8%
Short-Term Investments$4.1B-3.0%$3.9B-8.8%$3.9B-11.3%$4.0B-7.3%$4.2B-5.7%$4.3B-0.9%$4.4B+0.3%$4.3B+1.5%
Long-Term Investments$0n/m$0n/m$0n/m$0n/m$0n/m$0n/m$0n/m$0n/m
GoodwillN/AN/AN/A$2.0B+17.2%N/AN/AN/A$1.7B+34.6%
Total Liabilities$11.5B-0.1%$11.8B+1.9%$12.3B+1.9%$11.5B+3.2%$11.5B+4.7%$11.6B+12.2%$12.1B+9.6%$11.1B+4.3%
Current Liabilities$7.4B-1.2%$7.7B-2.2%$8.2B+0.4%$7.4B-6.6%$7.5B-10.3%$7.9B+0.5%$8.2B-4.2%$7.9B-3.3%
Non-Current Liabilities$4.1B+1.9%$4.1B+10.8%$4.1B+5.2%$4.1B+27.3%$4.0B+51.9%$3.7B+48.8%$3.9B+56.5%$3.2B+29.1%
Long-Term Debt$3.8B+2.9%$3.8B+11.7%$3.8B+5.4%$3.8B+28.8%$3.7B+57.1%$3.4B+54.7%$3.6B+63.9%$2.9B+34.1%
Total Equity$4.2B-0.9%$4.2B-9.4%$4.1B-5.3%$4.1B-9.5%$4.2B-12.1%$4.6B-5.0%$4.3B-4.1%$4.5B+6.7%
Retained Earnings$3.7B-1.3%$3.7B-11.6%$3.6B-7.4%$3.6B-12.0%$3.8B-13.0%$4.2B-7.4%$3.9B-6.8%$4.1B+5.2%

Not reported in any period shown, so not listed: Inventory, Accounts Receivable.

MOH Cash Flow Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

MOH quarterly cash flow statement
MetricQ3'2610-QQ2'2610-QQ1'2610-QQ4'2510-KQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-K
Operating Cash Flow-$159.0Mn/m-$294.0Mn/m$1.1B+469.5%-$298.0Mn/m-$125.0M-114.3%-$302.0Mn/m$190.0M-11.2%-$224.0Mn/m
Depreciation & Amortization$38.0M-15.6%$40.0M-31.0%$39.0M-18.8%$44.0M-8.3%$45.0M-4.3%$58.0M+26.1%$48.0M+6.7%$48.0M+11.6%
Stock-Based CompensationN/AN/A$33.0M+22.2%N/AN/AN/A$27.0M-25.0%N/A
Capital Expenditures$37.0M-2.6%$30.0M-28.6%$27.0M+22.7%N/A$38.0M+8.6%$42.0M+55.6%$22.0M-18.5%$11.0M
Free Cash Flow-$196.0Mn/m-$324.0Mn/m$1.1B+528.0%N/A-$163.0M-119.5%-$344.0Mn/m$168.0M-10.2%-$235.0M
Investing Cash Flow-$309.0M-501.3%-$30.0M-123.4%$11.0Mn/m$230.0M+1110.5%$77.0Mn/m$128.0M+141.5%-$123.0Mn/m$19.0Mn/m
Financing Cash Flow-$7.0Mn/m-$4.0Mn/m-$20.0M-113.6%$92.0M+37.3%-$220.0Mn/m-$189.0M-1675.0%$147.0Mn/m$67.0M+2133.3%
Share Buybacks$0-100.0%$0n/m$0-100.0%$0-100.0%$500.0M0.0%$0n/m$500.0Mn/m$500.0Mn/m

Not reported in any period shown, so not listed: Dividends Paid.

MOH Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

MOH quarterly financial ratios
MetricQ3'2610-QQ2'2610-QQ1'2610-QQ4'2510-KQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-K
Operating Margin1.0%-0.2pp1.3%-1.9pp0.8%-3.1pp-1.4%-5.0pp1.2%-3.3pp3.3%-1.1pp3.9%-0.4pp3.6%+0.1pp
Net Margin0.3%-0.4pp0.5%-1.7pp0.1%-2.5pp-1.4%-3.8pp0.7%-2.5pp2.2%-0.8pp2.7%-0.4pp2.4%0.0pp
Return on Equity0.9%-1.0pp1.4%-4.1pp0.3%-6.6pp-3.9%-9.5pp1.9%-5.0pp5.5%-0.7pp6.9%+0.2pp5.6%+0.5pp
Return on Assets0.2%-0.3pp0.4%-1.2pp0.1%-1.7pp-1.0%-2.6pp0.5%-1.6pp1.6%-0.4pp1.8%-0.1pp1.6%+0.2pp
Current Ratio1.690.0x1.680.0x1.630.0x1.69+0.1x1.68+0.1x1.66+0.1x1.63+0.1x1.62+0.1x
Debt-to-Equity0.910.0x0.90+0.2x0.92+0.1x0.93+0.3x0.87+0.4x0.73+0.3x0.83+0.3x0.65+0.1x
Liabilities-to-Equity2.770.0x2.84+0.3x3.02+0.2x2.83+0.3x2.75+0.4x2.52+0.4x2.80+0.3x2.48-0.1x
Asset Turnover0.710.0x0.680.0x0.660.0x0.73+0.1x0.73+0.1x0.71+0.1x0.680.0x0.67+0.1x
FCF Margin-1.8%-0.3pp-3.0%0.0pp9.8%+8.3ppN/A-1.4%-9.5pp-3.0%-0.5pp1.5%-0.4pp-2.2%

Not reported in any period shown, so not listed: Gross Margin.

Similar Companies

Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it. Market cap is stated at each company's latest close.

Company Fiscal year Revenue Net income Net margin Market cap Health score
Molina Healthcare, Inc. MOH FY2025 $45.4B $472.0M 1.0% $12.2B 62/100
Oscar Health, Inc. OSCR FY2025 $11.7B -$443.2M -3.8% $9.7B 45/100
Centene Corporation CNC FY2025 $194.8B -$6.7B -3.4% $37.0B 35/100
Elevance Health, Inc. ELV FY2025 $199.1B $5.7B 2.8% $96.4B 50/100
Humana Inc. HUM FY2025 $129.7B $1.2B 0.9% $55.4B 51/100
The Cigna Group CI FY2025 $274.9B $6.0B 2.2% $79.1B 53/100

Frequently Asked Questions

Molina Healthcare, Inc. (MOH) reported $45.4B in total revenue for fiscal year 2025. This represents a 11.7% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

Molina Healthcare, Inc. (MOH) revenue grew by 11.7% year-over-year, from $40.6B to $45.4B in fiscal year 2025.

Yes, Molina Healthcare, Inc. (MOH) reported a net income of $472.0M in fiscal year 2025, with a net profit margin of 1.0%.

Molina Healthcare, Inc. (MOH) reported diluted earnings per share of $8.92 for fiscal year 2025. This represents a -56.3% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Molina Healthcare, Inc. (MOH) had EBITDA of $976.0M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

As of fiscal year 2025, Molina Healthcare, Inc. (MOH) had $4.2B in cash and equivalents against $3.8B in long-term debt.

Molina Healthcare, Inc. (MOH) had an operating margin of 1.7% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

Molina Healthcare, Inc. (MOH) had a net profit margin of 1.0% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

Molina Healthcare, Inc. (MOH) has a return on equity of 11.6% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

Molina Healthcare, Inc. (MOH) recorded an outflow of $636.0M in free cash flow during fiscal year 2025. This represents a -216.9% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

Molina Healthcare, Inc. (MOH) recorded an outflow of $535.0M in operating cash flow during fiscal year 2025, representing cash used by core business activities.

Molina Healthcare, Inc. (MOH) had $15.6B in total assets as of fiscal year 2025, including both current and long-term assets.

Molina Healthcare, Inc. (MOH) invested $101.0M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

Yes, Molina Healthcare, Inc. (MOH) spent $1.0B on share buybacks during fiscal year 2025, returning capital to shareholders by reducing shares outstanding.

Molina Healthcare, Inc. (MOH) had 52M shares outstanding as of fiscal year 2025.

Molina Healthcare, Inc. (MOH) had a current ratio of 1.69 as of fiscal year 2025, which is generally considered healthy.

Molina Healthcare, Inc. (MOH) had a debt-to-equity ratio of 0.93 as of fiscal year 2025. We compute it as long-term debt divided by total shareholder equity, where long-term debt is the noncurrent part of the company's borrowings, so debt due within the next twelve months is not counted.

Molina Healthcare, Inc. (MOH) had a liabilities-to-equity ratio of 2.83 as of fiscal year 2025, which is total liabilities divided by total shareholder equity. Total liabilities counts every obligation on the balance sheet (payables, deposits, insurance reserves and deferred taxes as well as borrowings), so this ratio usually runs well above debt-to-equity.

Molina Healthcare, Inc. (MOH) had a return on assets of 3.0% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

Molina Healthcare, Inc. (MOH) has no price-to-earnings ratio at the moment: net loss, so no earnings multiple (trailing 12 months to September 30, 2026). The market capitalization is $12.2B as of Nov 16, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

Molina Healthcare, Inc. (MOH) trades at 0.3x sales, its market capitalization divided by $44.1B revenue, trailing 12 months to September 30, 2026. The market capitalization is $12.2B as of Nov 16, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

Molina Healthcare, Inc. (MOH) has an Altman Z-Score of 4.43, placing it in the Safe Zone (low bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

Molina Healthcare, Inc. (MOH) has a Piotroski F-Score of 4 out of 8 computable signals; 1 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

For every $1 of reported earnings, Molina Healthcare, Inc. (MOH) used $1.13 of operating cash (-$535.0M OCF vs $472.0M net income). Earnings that no cash stands behind rest on accounting accruals, which cannot be repeated indefinitely. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Molina Healthcare, Inc. (MOH) has an interest coverage ratio of 4.07x, meaning it can adequately cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

Molina Healthcare, Inc. (MOH) scores 62 out of 100 on our Financial Health Score, indicating moderate standing within its operating companies peer group. The score is the average of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.

Back to top